Managing symptoms of irritable bowel syndrome in patients with inflammatory bowel disease.
作者信息
Camilleri Michael
机构信息
Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Mayo Clinic, Rochester, MN 55905, USA.
出版信息
Gut. 2011 Apr;60(4):425-8. doi: 10.1136/gut.2010.234583. Epub 2011 Feb 2.
Abstract
摘要
相似文献
1
Managing symptoms of irritable bowel syndrome in patients with inflammatory bowel disease.
Gut. 2011 Apr;60(4):425-8. doi: 10.1136/gut.2010.234583. Epub 2011 Feb 2.
2
Inflammatory Bowel Disease and Irritable Bowel Syndrome: What to Do When There Is an Overlap.
Inflamm Bowel Dis. 2018 Nov 29;24(12):2479-2482. doi: 10.1093/ibd/izy277.
3
[Irritable bowel syndrome].
MMW Fortschr Med. 2010 Nov 4;152(44):73-6; quiz 77.
4
Evaluation of chronic diarrhea and irritable bowel syndrome with diarrhea in adults in the era of precision medicine.
Am J Gastroenterol. 2018 May;113(5):660-669. doi: 10.1038/s41395-018-0032-9. Epub 2018 May 1.
5
[Debatable aspects of pathogenesis and diagnostics of irritable bowel syndrome (IBS) and inflammatory bowel diseases with IBS-like diseases].
Klin Med (Mosk). 2010;94(10):795-800.
6
Irritable bowel syndrome: modern concepts and management options.
Am J Med. 2015 Aug;128(8):817-27. doi: 10.1016/j.amjmed.2015.01.036. Epub 2015 Feb 28.
7
[Gut Microbiota and Internal Diseases: Update Information. Topics: 1. The role of the gut microiota on inflammatory bowel disease (IBD)) and irritable bowel syndrome (IBS)].
Nihon Naika Gakkai Zasshi. 2015 Jan 10;104(1):35-41. doi: 10.2169/naika.104.35.
8
Overlapping irritable bowel syndrome and inflammatory bowel disease.
Minerva Gastroenterol Dietol. 2019 Jun;65(2):107-115. doi: 10.23736/S1121-421X.19.02559-5. Epub 2019 Feb 11.
9
[Comparison of symptoms, laboratory parameters and illness perception in patients with irritable bowel syndrome and inflammatory bowel disease].
Orv Hetil. 2015 Jun 7;156(23):933-8. doi: 10.1556/650.2015.30168.
10
Investigating young adults with chronic diarrhoea in primary care.
BMJ. 2015 Feb 25;350:h573. doi: 10.1136/bmj.h573.
引用本文的文献
1
Single-cell transcriptomics reveals activation of endothelial cell and identifies LHPP as a potential target in ulcerative colitis.
Heliyon. 2024 Apr 3;10(7):e29163. doi: 10.1016/j.heliyon.2024.e29163. eCollection 2024 Apr 15.
2
Smooth muscle dysfunction in the pre-inflammation site in stenotic Crohn's-like colitis: implication of mechanical stress in bowel dysfunction in gut inflammation.
Front Physiol. 2023 Jul 14;14:1215900. doi: 10.3389/fphys.2023.1215900. eCollection 2023.
3
Cancer Immunotherapy: The Checkpoint between Chronic Colitis and Colorectal Cancer.
Cancers (Basel). 2022 Dec 12;14(24):6131. doi: 10.3390/cancers14246131.
4
Enhancing High Value Care in Gastroenterology Practice.
Clin Gastroenterol Hepatol. 2016 Oct;14(10):1376-84. doi: 10.1016/j.cgh.2016.05.022. Epub 2016 May 20.
5
Diagnosis and management of functional symptoms in inflammatory bowel disease in remission.
World J Gastrointest Pharmacol Ther. 2016 Feb 6;7(1):78-90. doi: 10.4292/wjgpt.v7.i1.78.
6
Self-reported Symptom Burden in Individuals with Inflammatory Bowel Disease.
J Crohns Colitis. 2016 Mar;10(3):315-22. doi: 10.1093/ecco-jcc/jjv218. Epub 2015 Nov 22.
7
Irritable bowel syndrome: how useful is the term and the 'diagnosis'?
Therap Adv Gastroenterol. 2012 Nov;5(6):381-6. doi: 10.1177/1756283X12442223.
8
Pain management in patients with inflammatory bowel disease: insights for the clinician.
Therap Adv Gastroenterol. 2012 Sep;5(5):339-57. doi: 10.1177/1756283X12446158.
9
Refractory inflammatory bowel disease-could it be an irritable bowel?
Nat Rev Gastroenterol Hepatol. 2013 Jan;10(1):58-61. doi: 10.1038/nrgastro.2012.173. Epub 2012 Sep 11.
10
Targeting mucosal healing in Crohn's disease.
Gastroenterol Hepatol (N Y). 2011 Jun;7(6):374-80.
本文引用的文献
1
Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity.
Inflamm Bowel Dis. 2011 Aug;17(8):1759-68. doi: 10.1002/ibd.21551. Epub 2010 Nov 8.
2
Bile acid malabsorption in inflammatory bowel disease: assessment by serum markers.
Inflamm Bowel Dis. 2011 Jun;17(6):1322-7. doi: 10.1002/ibd.21502. Epub 2010 Nov 5.
3
Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndrome.
BMC Gastroenterol. 2010 Oct 14;10:118. doi: 10.1186/1471-230X-10-118.
4
Inflammatory bowel disease, irritable bowel syndrome, or what?: A challenge to the functional-organic dichotomy.
Am J Gastroenterol. 2010 Aug;105(8):1796-8. doi: 10.1038/ajg.2010.162.
5
Irritable pouch syndrome is characterized by visceral hypersensitivity.
Inflamm Bowel Dis. 2011 Apr;17(4):994-1002. doi: 10.1002/ibd.21412.
6
Irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: a real association or reflection of occult inflammation?
Am J Gastroenterol. 2010 Aug;105(8):1788, 1789-94; quiz 1795. doi: 10.1038/ajg.2010.156. Epub 2010 Apr 13.
7
Do the Symptom-Based, Rome Criteria of Irritable Bowel Syndrome Lead to Better Diagnosis and Treatment Outcomes? The Con Argument.
Clin Gastroenterol Hepatol. 2009 Oct 20;8(2):129. doi: 10.1016/j.cgh.2009.10.009.
8
Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort.
Neurogastroenterol Motil. 2010 Mar;22(3):293-e82. doi: 10.1111/j.1365-2982.2009.01442.x. Epub 2009 Dec 21.
9
The geoepidemiology of autoimmune intestinal diseases.
Autoimmun Rev. 2010 Mar;9(5):A372-8. doi: 10.1016/j.autrev.2009.11.008. Epub 2009 Nov 10.
10
Small intestinal bacterial overgrowth mimicking acute flare as a pitfall in patients with Crohn's Disease.
BMC Gastroenterol. 2009 Jul 30;9:61. doi: 10.1186/1471-230X-9-61.
Zotero 插件